Status:
COMPLETED
Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis.
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Postmenopausal Osteoporosis
Eligibility:
FEMALE
Up to 85 years
Phase:
PHASE2
Brief Summary
Dose-response in Japanese patients with postmenopausal osteoporosis.
Eligibility Criteria
Inclusion
- Must be postmenopausal and diagnosed as osteoporosis based on bone mineral density and/or vertebral fracture.
Exclusion
- Diseases which possibly induce secondary osteoporosis or osteopenia and affect on bone metabolism.
Key Trial Info
Start Date :
August 1 2003
Trial Type :
INTERVENTIONAL
End Date :
March 1 2007
Estimated Enrollment :
375 Patients enrolled
Trial Details
Trial ID
NCT00238745
Start Date
August 1 2003
End Date
March 1 2007
Last Update
December 20 2007
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.